David Millar calls for Bradley Wiggins's TUE medication to be banned
David Millar explains his experience with the triamcinolone drug that was prescribed to Bradley Wiggins, describing it as "powerful" and "destructive"
David Millar is calling on the World Anti-Doping Agency (WADA) to completely ban the corticosteroid used by Sir Bradley Wiggins during his time with Team Sky, calling the drug "powerful" and "destructive".
In a data leak last week it was revealed that Wiggins received six therapeutic use exemptions (TUEs) during his career, three for triamcinolone, which was used to treat a pollen allergy.
Wiggins's use of the drug was sanctioned by the UCI ahead of the 2011 and 2012 Tour de France and the 2013 Giro d'Italia. There is no suggestion of any wrongdoing by Wiggins.
In an interview with the Telegraph's Tom Cary, Millar described his experience of the drug, saying Kenacort – a trade name for triamcinolone - "put you on this weird high”, having used it himself in the past.
The former Garmin professional, who served a two year ban for drug use in his early career and is now an active anti-doping campaigner, did not comment on the Wiggins case, but shared his experience of Kenacort.
“You would do all the training but my weight would stick,” he said, referencing his own use of EPO and testosterone patches. “But if I took Kenacort, 1.5-2kgs would drop off in like a week. And not only would the weight drop off I would feel stronger.
“If you are non-asthmatic and you take Ventolin it’s not going to give you any advantage. But if you take Kenacort it’s not only going to make a sick person better, it’s going to make a sick person better than a healthy person. That’s a very grey area.
Get The Leadout Newsletter
The latest race content, interviews, features, reviews and expert buying guides, direct to your inbox!
“I’m sure there are other forms of cortisone that could be used for allergies which aren’t so potent or performance-enhancing.” He added: “We [athletes] shouldn’t have to face this. If it’s that strong we shouldn’t be allowed to take it unless there is a serious issue.
"And if we’re suffering from that serious an issue, we shouldn’t be racing. I don’t know how a doctor could prescribe it [before a race]. I can’t fathom it.”
In a statement released on Wiggins's behalf following the data leak, it was insisted there was "nothing new" in the revelations, which have left the 2012 Tour champion under fire due to his his previous statements regarding Team Sky's 'no-needle' policy.
“The triamcinolone injection that is referred to in the WADA leaks is an intramuscular treatment for asthma and is fully approved by the sport’s governing bodies," the statement read.
Thank you for reading 20 articles this month* Join now for unlimited access
Enjoy your first month for just £1 / $1 / €1
*Read 5 free articles per month without a subscription
Join now for unlimited access
Try first month for just £1 / $1 / €1
Stuart Clarke is a News Associates trained journalist who has worked for the likes of the British Olympic Associate, British Rowing and the England and Wales Cricket Board, and of course Cycling Weekly. His work at Cycling Weekly has focused upon professional racing, following the World Tour races and its characters.
-
We rode and reviewed the Ouray, Parlee Cycles' first new bike model since facing bankruptcy
The storied American brand continues with a Portugal-made carbon steed that goes zoom but doesn’t fit like a race bike
By Tyler Boucher Published
-
Forget distance covered, these are the key stats to note in your Strava Year in Sport
We asked a coach how to best analyse our end of year Strava data
By Tom Davidson Published
-
Tom Pidcock signs for Q36.5 Pro Cycling after Ineos Grenadiers departure
Olympic MTB champion hails 'start of something special' in three-year deal
By Tom Thewlis Published
-
Steve Cummings takes sports director role at Jayco AIUla after Ineos Grenadiers departure
'It’s an opportunity to be part of a culture that celebrates growth, resilience, and meaningful results' says 43-year-old after joining new team
By Tom Thewlis Published
-
'With a few changes, it'll be class' - Josh Tarling optimistic about Ineos Grenadiers future
'Everybody wants to get better and get back to winning,' 20-year-old tells audience at Rouleur Live
By Tom Davidson Published
-
'We've had a difficult year, I've had a difficult year' - Tom Pidcock hints at Ineos Grenadiers tension
Speaking at Rouleur Live, the 25-year-old also revealed that he hasn't enjoyed racing at the last two Tours de France
By Adam Becket Published
-
Ineos Grenadiers to partner with German development team for 2025
Ineos set to partner with German Continental squad Lotto Kern-Haus PSD Bank as an official development partner
By Tom Thewlis Published
-
Where next for Ineos Grenadiers, now Steve Cummings has officially left?
After the Director of Racing's exit, the Tom Pidcock saga needs a final resolution before the team can move forward
By Tom Thewlis Published
-
Ineos' Director of Racing, Steve Cummings, confirms he is leaving the team after not attending a race since June
Announcement comes after months of uncertainty surrounding Cummings' position
By Tom Thewlis Published
-
'I never thought I'd really leave the team': Luke Rowe opens up on his reasons for departing Ineos Grenadiers
Welsh road captain is heading to Decathlon AG2R La Mondiale to become a sports director
By Adam Becket Published